GGrantIndex
Sort

39,280 grants matching leukemia

Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer

$585,953
Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA

Preclinical development and clinical monitoring of adoptive immune therapy

$585,861
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Immune reconstitution following autologous and allogeneic stem cell transplant

$585,861
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

"Off-the-Shelf" iPSC-Derived Regulatory T Cell Immunotherapeutics

$585,829
Bruce R. Blazar · University Of Minnesota · P01 · FY2025 · CA

Diazeniumdiolates as Broad-Spectrum Anticancer Agents

$585,804
Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Lab Research Training in Pediatric Oncology-Hematology

$585,732
Alan D Friedman · Johns Hopkins University · T32 · FY2023 · CA

COPII dependent regulation of T cell alloimmunity

$585,730
Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

COPII dependent regulation of T cell alloimmunity

$585,730
Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2021 · HL

COPII dependent regulation of T cell alloimmunity

$585,730
Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2020 · HL

Proteogenomic Analysis of Platelets in Thrombocythemia

$585,655
Massachusetts General Hospital · R01 · FY2005 · HL

Kansas City Clincal Oncology Program CCOP

$585,600
Rakesh Gaur · Nci Community Oncology Research Program · U10 · FY2013 · CA

Protein Characterization By Mass Spectrometry

$585,540
Kenneth Tomer · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Genetic characterization of osteoblast-induced leukemias

$585,485
Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2016 · HL

Viscoelasticity and T Cell Production

$585,468
David J Mooney · Harvard University · R01 · FY2024 · CA

IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES

$585,447
Warren S Pear · University Of Pennsylvania · T32 · FY2019 · CA

MOLECULAR SIGNATURES FOR OUTCOME PREDICTION AND THERAPEUTIC TARGETING IN ALL

$585,133
Cheryl L Willman · University Of New Mexico Health Scis Ctr · U01 · FY2012 · CA

Achieving Xenograft Tolerance through Thymic Programming in Primates

$585,121
Kazuhiko Yamada · Columbia University Health Sciences · P01 · FY2025 · AI

Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AML

$585,107
Ranjit Bindra · Yale University · R01 · FY2025 · CA

Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AML

$585,106
Ranjit Bindra · Yale University · R01 · FY2022 · CA

Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect

$585,063
Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Structural insights into the MLL core complexes

$584,982
Yali Dou · University Of Southern California · R01 · FY2024 · CA

Causes and consequences of genomic instability in myelodysplasia

$584,872
Stanley Chun-Wei Lee · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Identification of causal factors underlying cognitive deficits in a mouse model of childhood leukemia survival

$584,779
Teresa M Reyes · University Of Cincinnati · R01 · FY2021 · NR

Botswana Birth Outcomes Surveillance Extension

$584,759
Roger L Shapiro · Harvard School Of Public Health · R01 · FY2021 · HD

PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)

$584,686
St. Jude Children'S Research Hospital · R37 · FY2005 · CA